MTBC Kicks off Q2 Exhibiting at Specialty Conferences in Wisconsin, California and Nevada
Apr 07, 2016 16:45 pm UTC| Business
SOMERSET, N.J., April 07, 2016 -- MTBC (NASDAQ:MTBC), a leading provider of proprietary, healthcare information technology solutions today announced that its second quarter is off to an exciting start as its sales team...
Apr 07, 2016 16:45 pm UTC| Business
CHARLOTTE, N.C., April 07, 2016 -- Capital Bank Financial Corp. (Nasdaq:CBF) today announced that it will release its first-quarter 2016 financial results on Friday, April 22, 2016, and management will host a conference...
Advance Notice of First-Quarter Financial Results for Shell Midstream Partners, L.P.
Apr 07, 2016 16:30 pm UTC| Business
Houston, April 07, 2016 -- Advance Notice of First-Quarter Financial Results for Shell Midstream Partners, L.P. Houston, Texas, April 7, 2016 -- Shell Midstream Partners, L.P. (NYSE: SHLX) will host a conference call...
Forced USPS Price Reduction Begins This Weekend
Apr 07, 2016 16:17 pm UTC| Business
WASHINGTON, April 7, 2016 -- The Postal Service will lose approximately $2 billion in annual revenue resulting from a price reduction mandated by the Postal Regulatory Commission (PRC) — which will go into effect...
Apr 07, 2016 16:16 pm UTC| Business
NEW YORK, April 07, 2016 -- The following statement is being issued by Levi Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Navient Corporation (“Navient”) (NASDAQ:NAVI)...
Four core focus areas for successful automotive experiential events, according to Foresight Research
Apr 07, 2016 16:16 pm UTC| Business
ROCHESTER, Mich., April 07, 2016 -- Experiential marketing is hot for new auto buyers according to the 2015 Foresight Research Promotions Immersion Report™. New car buyers were twice as likely to attend an event versus...
Galectin Therapeutics to Present at Needham & Company’s 15th Annual Healthcare Conference
Apr 07, 2016 16:11 pm UTC| Business
NORCROSS, Ga., April 07, 2016 -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that Peter G. Traber, M.D.,...